Heplisav B ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

heplisav b

dynavax gmbh - hepatitt b overflate antigen - hepatitt b - vaksiner - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Qaialdo ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.

Ontozry ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - epilepsi - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Jardiance ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

jardiance

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - legemidler som brukes i diabetes - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

Neuraceq ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

neuraceq

life molecular imaging gmbh - florbetaben (18f) - radionuclide imaging; alzheimer disease - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. neuraceq er en radiopharmaceutical indikert for positron emisjon tomografi (pet) avbildningen av amyloid-β neuritic plakk tetthet i hjernen hos voksne pasienter med kognitiv svikt som blir vurdert for alzheimers sykdom (ad) og andre årsaker til kognitiv svikt. neuraceq skal brukes i forbindelse med en klinisk vurdering. en negativ søk angir sparsom eller ingen plakk, som ikke er forenlig med diagnosen ad.

Maviret ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

maviret

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitt c, kronisk - antivirale midler til systemisk bruk - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.

Clindamycin Navamedic 150 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

clindamycin navamedic 150 mg/ ml

navamedic asa - klindamycinfosfat - injeksjonsvæske/konsentrat til infusjonsvæske, oppløsning - 150 mg/ ml

Dalacin 150 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

dalacin 150 mg/ ml

pfizer as - klindamycinfosfat - injeksjonsvæske, oppløsning - 150 mg/ ml

Dalacin 15 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

dalacin 15 mg/ ml

pfizer as - klindamycinpalmitathydroklorid - granulat til mikstur, oppløsning - 15 mg/ ml